Liaoning Cheng Da Co., Ltd. (SHA:600739)
10.67
-0.18 (-1.66%)
May 22, 2025, 2:45 PM CST
Liaoning Cheng Da Revenue
Liaoning Cheng Da had revenue of 2.57B CNY in the quarter ending March 31, 2025, with 4.39% growth. This brings the company's revenue in the last twelve months to 11.40B, up 1.98% year-over-year. In the year 2024, Liaoning Cheng Da had annual revenue of 11.29B with 4.70% growth.
Revenue (ttm)
11.40B
Revenue Growth
+1.98%
P/S Ratio
1.42
Revenue / Employee
3.44M
Employees
3,317
Market Cap
16.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.29B | 506.45M | 4.70% |
Dec 31, 2023 | 10.78B | -3.78B | -25.97% |
Dec 31, 2022 | 14.56B | -3.81B | -20.73% |
Dec 31, 2021 | 18.37B | 1.43B | 8.43% |
Dec 31, 2020 | 16.94B | -800.78M | -4.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |